(Q36317204)

13 August 2017

1 reference

title

Natriuretic peptides in acute and chronic kidney disease and during renal replacement therapy (English)

1 reference

chronic renal insufficiency

13 August 2017

main subject

1 reference

Walter H Hörl

1

1 reference

13 August 2017

publication date

1 November 2005

1 reference

Journal of Investigative Medicine

13 August 2017

published in

1 reference

13 August 2017

volume

53

1 reference

13 August 2017

issue

7

1 reference

13 August 2017

page(s)

366-370

1 reference

Modulation of cardiac natriuretic peptide gene expression following endothelin type A receptor blockade in renovascular hypertension.

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.2310%2F6650.2005.53709

Diagnostic potential of cardiac natriuretic peptides in dialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.2310%2F6650.2005.53709

Plasma adrenomedullin and natriuretic peptides in patients with essential or malignant hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.2310%2F6650.2005.53709

Brain natriuretic peptide in hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.2310%2F6650.2005.53709

Relationship between left ventricular geometry and natriuretic peptide levels in essential hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.2310%2F6650.2005.53709

Left ventricular mass relates to average systolic blood pressure, but not loss of circadian blood pressure in stable hemodialysis patients: an ambulatory 48-hour blood pressure study.

21 January 2018

1 reference

https://api.crossref.org/works/10.2310%2F6650.2005.53709

Adsorption of natriuretic factors in uremia

21 January 2018

1 reference

https://api.crossref.org/works/10.2310%2F6650.2005.53709

Plasma brain natriuretic peptide levels in chronic hemodialysis patients: influence of coronary artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.2310%2F6650.2005.53709

Plasma brain natriuretic peptide concentration on assessment of hydration status in hemodialysis patient

21 January 2018

1 reference

https://api.crossref.org/works/10.2310%2F6650.2005.53709

Central blood volume, atrial natriuretic peptide and intermittent hemodialysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.2310%2F6650.2005.53709

Effects of the creation of arteriovenous fistula for hemodialysis on cardiac function and natriuretic peptide levels in CRF.

21 January 2018

1 reference

https://api.crossref.org/works/10.2310%2F6650.2005.53709

Plasma levels of brain and atrial natriuretic peptides elevate in proportion to left ventricular end-systolic wall stress in patients with aortic stenosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.2310%2F6650.2005.53709

Natriuretic peptides in patients with aortic stenosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.2310%2F6650.2005.53709

Increased plasma natriuretic peptide levels reflect symptom onset in aortic stenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2310%2F6650.2005.53709

Natriuretic peptides predict symptom-free survival and postoperative outcome in severe aortic stenosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.2310%2F6650.2005.53709

Neurohormonal risk stratification for sudden death and death owing to progressive heart failure in chronic heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.2310%2F6650.2005.53709

Circulating natriuretic peptide concentrations in patients with end-stage renal disease: role of brain natriuretic peptide as a biomarker for ventricular remodeling.

21 January 2018

1 reference

https://api.crossref.org/works/10.2310%2F6650.2005.53709

Intraperitoneal atrial natriuretic peptide increases peritoneal fluid and solute removal

21 January 2018

1 reference

https://api.crossref.org/works/10.2310%2F6650.2005.53709

N-terminal fragments of the proatrial natriuretic peptide in plasma and urine of kidney graft recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.2310%2F6650.2005.53709

Ventricular atriopeptin. Unmasking of messenger RNA and peptide synthesis by hypertrophy or dexamethasone.

21 January 2018

1 reference

https://api.crossref.org/works/10.2310%2F6650.2005.53709

Atrial natriuretic peptide causes pre-glomerular vasodilatation and post-glomerular vasoconstriction in rat kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.2310%2F6650.2005.53709

Atrial natriuretic factor in renal failure and posthemodialytic postural hypotension

21 January 2018

1 reference

https://api.crossref.org/works/10.2310%2F6650.2005.53709

In vitro and in vivo protective effect of atriopeptin III on ischemic acute renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.2310%2F6650.2005.53709

Amelioration of postischaemic acute renal failure in conscious dogs by human atrial natriuretic peptide.

21 January 2018

1 reference

https://api.crossref.org/works/10.2310%2F6650.2005.53709

Atrial natriuretic peptide protects against acute ischemic renal failure in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.2310%2F6650.2005.53709

Effects of kaliuretic peptide on sodium and water excretion in persons with congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.2310%2F6650.2005.53709

Vessel dilator enhances sodium and water excretion and has beneficial hemodynamic effects in persons with congestive heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.2310%2F6650.2005.53709

21 January 2018

Identifiers

DOI

10.2310/6650.2005.53709

1 reference

13 August 2017

1 reference